644 related articles for article (PubMed ID: 4581047)
21. Approaches to immunotherapy.
McKhann CF; Gunnarsson A
Cancer; 1974 Oct; 34(4 Suppl):suppl:1521-31. PubMed ID: 4608719
[No Abstract] [Full Text] [Related]
22. [The immunotherapeutic approaches to the management of leukemia and neoplasms].
Leu TP
Zhonghua Yi Xue Za Zhi; 1974 May; 5():310-4. PubMed ID: 4211699
[No Abstract] [Full Text] [Related]
23. Manipulation of immunologically reactive cell populations in vitro. Outline of an approach to specific immunotherapy of cancer.
Bach ML; Bach FH; Zoschke DC
Isr J Med Sci; 1973 Mar; 9(3):344-9. PubMed ID: 4145460
[No Abstract] [Full Text] [Related]
24. Cancer topics: immunology and cancer revisited.
O'Brien PH
J S C Med Assoc; 1974 Jul; 70(7):223-6. PubMed ID: 4603086
[No Abstract] [Full Text] [Related]
25. Cancer immunotherapy with surgery.
Orita K; Miwa H; Mannami T; Konaga E; Yumura M
Acta Med Okayama; 1977 Aug; 31(4):217-34. PubMed ID: 145159
[TBL] [Abstract][Full Text] [Related]
26. [Immunotherapy of malignant tumors].
Adolphs HD
Med Klin; 1975 Feb; 70(7):255-66. PubMed ID: 1091835
[No Abstract] [Full Text] [Related]
27. [Immunotherapy of neoplasms].
Trepel F
Med Klin; 1971 Feb; 66(7):222-9. PubMed ID: 4324109
[No Abstract] [Full Text] [Related]
28. Introduction: diagnosis and immunotherapy of cancer.
Klein E
Natl Cancer Inst Monogr; 1972 Dec; 35():331-9. PubMed ID: 4349151
[No Abstract] [Full Text] [Related]
29. Immunologic aspects of cancer.
Sophocles AM; Nadler SH
Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
[No Abstract] [Full Text] [Related]
30. Immunological aspects of malignant melanoma of the choroid.
Rahi AH
Trans Ophthalmol Soc U K (1962); 1973; 93(0):79-91. PubMed ID: 4602170
[No Abstract] [Full Text] [Related]
31. Immunologic aspects of malignancy: Factors of concern in the prospective candidate for immunotherapy.
Ablin RJ
Allergol Immunopathol (Madr); 1975; 3(2):105-8. PubMed ID: 1155313
[No Abstract] [Full Text] [Related]
32. Effect of whole and lysed sensitized lymphocytes on murine tumor growth and host survival.
Greco RS; Schmidt DR; Storer EH
Surg Forum; 1973; 24():109-11. PubMed ID: 4808028
[No Abstract] [Full Text] [Related]
33. Cellular and humoral immune interactions during neoplastic development.
Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
[No Abstract] [Full Text] [Related]
34. Cell-mediated immune mechanisms of tumor cell destruction.
Perlmann P; O'Toole C; Unsgaard B
Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
[No Abstract] [Full Text] [Related]
35. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
[No Abstract] [Full Text] [Related]
36. "Immune" RNA--a new model for the immunotherapy of cancer.
Pilch YH
Cancer Chemother Rep 3; 1973 Mar; 4(2):287-92. PubMed ID: 4729332
[No Abstract] [Full Text] [Related]
37. [Cancer and the lymphatic system].
Grekh IF
Vopr Onkol; 1971 Sep; 17(10):101-10. PubMed ID: 4947716
[No Abstract] [Full Text] [Related]
38. Transfer factor in cellular immunity.
Lawrence HS
Harvey Lect; 1974; 68():239-350. PubMed ID: 4616018
[No Abstract] [Full Text] [Related]
39. [Immune surveillance in neoplasms].
Schneeweiss U
Z Exp Chir; 1974; 7(4):204-15. PubMed ID: 4440030
[No Abstract] [Full Text] [Related]
40. Transfer of tumor-specific immunity with RNA: demonstration by immune cytolysis of tumor cells in vitro.
Ramming KP; Pilch YH
J Natl Cancer Inst; 1970 Sep; 45(3):543-53. PubMed ID: 5523195
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
